# FDA Inspection 882510 - Summa St Thomas Hospital - June 10, 2014

Source: https://www.keypedia.com/records/fda_inspections/summa-st-thomas-hospital/b77be47c-b2f6-4713-a99f-fc4e675675b1
Source feed: FDA_Inspections

> FDA Inspection 882510 for Summa St Thomas Hospital on June 10, 2014. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 882510
- Company Name: Summa St Thomas Hospital
- Inspection Date: 2014-06-10
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 796556 - 2012-08-29](https://www.keypedia.com/records/fda_inspections/summa-st-thomas-hospital/41d1996e-75cc-44a5-8cd3-560d799e452e)
- [FDA Inspection 662254 - 2010-05-14](https://www.keypedia.com/records/fda_inspections/summa-st-thomas-hospital/83f1da62-ba6f-4b29-b9e3-34c57b78c4ce)

Company: https://www.keypedia.com/companies/summa-st-thomas-hospital/ba893b63-ed99-473e-974f-cd650740978c

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d